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Myeloid derived suppressor cells (MDSC, CD33+CD11b+
HLA-DR low/-) play a major role in tumor-mediated
immune evasion and are composed of at least 3 subsets
PMN (CD15+), monocytic (CD14+) and lineage-negative
(CD15-CD14-), and each has been shown to be signifi-
cantly increased in some human tumor types and to corre-
late with metastatic burden, clinical cancer stage and
outcome. Less in known about the MDSC subsets that
accumulate in tumors such as renal cell carcinoma (RCC)
and the cytokines/chemokines involved in their recruit-
ment. Flow cytometry analysis of peripheral blood mono-
nuclear cells (PBMC, n = 20) and nephrectomy samples
(n = 39, stage 1-4) showed increased levels of total MDSC
in RCC patients compared to normal controls (n = 15),
with PMN- and Lin- MDSC subsets dominating in the
blood and tumor of RCC patients. Blood levels of total
MDSC, PMN-MDSC and Lin-MDSC correlated with
tumor grade (p = 0.026, p = 0.006 and p = 0.045, respec-
tively), while blood levels of total MDSC and Lin-MDSC
correlated with progression free survival (PFS) in patients
with limited stage disease (n = 16, stages 1-3) (HR = 1.35,
p = 0.03; HR = 1.45, p = 0.02, respectively). In the tumor,
higher PMN-MDSC levels were significantly associated
with decreased PFS (n = 29, HR = 1.09, p = 0.011).
To assess the role of select chemokines (IL-8, CXCL5,
Mip-1a, MCP-1 and Rantes) and of the pro-inflammatory
cytokine IL-1b in promoting the accumulation of MDSC
within the tumor, these proteins were quantitated in
tumor lysates by ELISA and correlated to MDSC frequen-
cies (Spearman correlations). We found a direct correla-
tion between the frequency of PMN-MDSC in the
parenchyma and the levels of IL-8 (p < 0.001), CXCL-5
(p < 0.001), and IL-1b (p = 0.029). Frequency of parenchy-
mal Lin- MDSC directly correlated with levels of IL-8
(p = 0.033) and CXCL-5 (p = 0.008), but not IL-1b. In cir-
culation, frequency of total MDSCs directly correlated
with IL-1b plasma levels (p = 0.003).
To further define the role of IL-1b in MDSC accumula-
tion within tumors, we overexpressed IL-1b in RENCA
and CT26 tumors and compared them to untransfected
tumors. Overexpression of IL-1b resulted in enhanced
tumor growth and increased frequency of intratumor
PMN-MDSC (10.3X in RENCA and 26X in CT26), with a
modest increase in intratumor M-MDSC. A large fraction
of tumor infiltrating PMN-MDSC expressed CXCR2 (84%
in RENCA and 55% in CT26), which is associated with a
significant increase in expression of CXCR2 ligands (KC,
CXCL5, and MIP2). These results support the idea that
IL-1b-mediated induction of select chemokines promotes
the accumulation of MDSC, particularly PMN-MDSC,
within tumors, resulting in enhanced immune suppression
and angiogenesis.
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